IDH3A and glioblastoma: Although glioblastoma (GBM), an isocitrate dehydrogenase-wildtype (IDH-wt) World Health Organization (WHO) grade 4 tumor, is one of the best molecularly characterized human malignancies, it still presents a significant clinical problem due to poor overall patient survival and limited treatment options.